BNET Industries
Last Fiscal Year Sales:$83.4M
- Private
- US
Dow Jones Description
Provider of Pharmaceutical & Biotechnology Products
CTO, Vice President & General Manager, Sys
John LilligNumber of Employees 133
Contact Information
9640 Towne Centre Dr
San Diego, California 92121-1963
(858) 455-8600
Peer Companies
NAICS Code Research and Development in the Social Sciences and Humanities: 541720
News & Analysis
Filter by
discovery partners international inc. - All News and Analysis
Bellwether Report.com is Doing Due Diligence on Discovery Partners International Inc.
M2 PRESSWIRE-28 August 2006-bellwetherreport.com: Bellwether Report.com is Doing Due Diligence on Discovery Partners International Inc.C1994-2006 M2 COMMUNICATIONS LTD RDATE:28082006 The Bellwether Report Takes Notice of Discovery Partners International Inc. (Nasdaq:DPII) Discovery Partners International DPI has taken on a...
Galapagos completes acquisition of drug discovery service operations of Discovery Partners International
Mechelen, Belgium; 6 July 2006 - Galapagos NV (Euronext & LSE: GLPG), an integrated drug discovery company, announced today closure on the acquisition of all the drug discovery operations of Discovery Partners International DPI for EUR 4.25 million in cash....
Galapagos to Acquire Drug Discovery Service Operations of Discovery Partners International
Acquisition positions BioFocus as top five player worldwide in drug discovery services Webcast Conference Call Scheduled for 10:30 AM CET today. * Galapagos will pay DPI EUR 4.25 million ($5.4 million) in cash * Four DPI research sites in US, Germany, and Switzerland will add breadth...
Market Gainer Issues Report On Discovery Partners International, Inc.
M2 PRESSWIRE-12 April 2006-marketgainer.com: Market Gainer Issues Report On Discovery Partners International, Inc.C1994-2006 M2 COMMUNICATIONS LTD RDATE:12042006 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets....
Seikagaku, Discovery Partners International Identify Drug Compound
Tokyo, Nov 11, 2005 - JCN - Seikagaku has identified several drug compound candidates that target sugar chain enzymes, in collaboration with its research partner Discovery Partners International DPI. By using Seikagaku's proprietary assay method and DPI's exclusive screening system, the two companies have discovered the compound...
Research services company Discovery Partners International selected TekCel's TubeStore System
Research services company Discovery Partners International selected TekCel's TubeStore System to manage part of the working samples at its NIH-funded small molecule repository.
Discovery Partners International, Inc. and Bruker AXS Inc. Announce New Bench top Protein Crystallization System
ORLANDO, Fla. -- Discovery Partners International, Inc. (NASDAQ: DPII) and Bruker AXS Inc., a subsidiary of Bruker BioSciences Corporation (NASDAQ: BRKR), together announced the launch of a bench top version of their popular CRYSTAL FARMTM product for high-throughput protein crystallization at the 2005 Pittsburgh Conference in Orlando. The new CRYSTAL...
Biovitrum AB and Discovery Partners International Inc sign cooperation agreement
NORDIC BUSINESS REPORT-14 December 2004-Biovitrum AB and Discovery Partners International Inc sign cooperation agreementC1994-2004 M2 COMMUNICATIONS LTD http://www.m2.com The Swedish biotechnology company Biovitrum AB said on Tuesday (14 December) that it had signed a drug discovery and development agreement with the US group Discovery Partners International Inc. The...
PROTEOMICS: Two Competitors Team Up.(Brief Article)
Current competitors, Discovery Partners International, Inc. (9640 Towne Centre Drive, San Diego, CA 92121, Tel: 858/455-8600, Website: discoverypartners.com) and Bruker AXS Inc., a subsidiary of Bruker BioSciences Corp. (40 Manning Rd., Billerica, MA 01821,Tel: 978/663-3660, Fax: 978-667-5993) have joined forces in a multi-year strategic...
Discovery Partners International Inc.
M2 PRESSWIRE-23 January 2003-Research and Markets: Discovery Partners International IncC1994-2003 M2 COMMUNICATIONS LTD RDATE:01232003 This company profile for Discovery Partners International Inc is taken directly from the BiotechWatch database. The BiotechWatch database is a continuously updated interactive database...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| John Lillig | CTO, Vice President & General Manager, Sys |
| Douglas A. Livingston | Senior Vice President |
| Daniel Harvey | Vice President & General Manager |
| Richard Neale | Vice President, Business Operations |
| Urs Regenass | Vice President & General Manager, Drug Discovery |
| Dr. Alan J. Lewis | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Colin T. Dollery | Board of Directors |
| Harry F. Hixson | Board of Directors |
| Herm Rosenman | Board of Directors |
| John P. Walker | Board of Directors |
| Michael C. Venuti | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Discovery Partners International, Inc. | CTO, Vice President & General Manager, Sys | Current |
| Organization | Position | Status |
|---|---|---|
| Discovery Partners International, Inc. | Senior Vice President | Current |
| La Jolla Pharmaceutical Company | Former | |
| Columbia University | Ph.D. in organic synthetic chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Discovery Partners International, Inc. | Vice President & General Manager | Current |
| Yale University | Ph.D. in synthetic organic chemistry | Former |
Mr. Neale joined Galapagos in October 2006 from Discovery Partners International where he was member of the Executive Management Team and held various positions involving strategic, commercial, corporate and operational aspects of the Company. Prior to DPI, he was Vice President, Business at Systems Integrated Drug Discovery Company and Vice President, Business Affairs and General Legal Counsel at Novopharm Biotech (now Viventia Biotech). Mr. Neale practiced law in the Corporate/Securities group of Davies Ward & Beck (now Davies Ward Phillips & Vineberg). He holds a Bachelor of Science degree from the University of Guelph and Masters of Business Administration and Law degrees from Dalhousie University.
| Organization | Position | Status |
|---|---|---|
| Galapagos nv | Senior Vice President North America | Current |
| Discovery Partners International, Inc. | Vice President, Business Operations | Current |
| Davies Ward Phillips & Vineberg Llp | Former | |
| University of Guelph | Bachelor of Science Degree | Former |
| Organization | Position | Status |
|---|---|---|
| Discovery Partners International, Inc. | Vice President & General Manager, Drug Discovery | Current |
| Organization | Position | Status |
|---|---|---|
| Discovery Partners International, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Juvenile Diabetes Research Foundation | President & Chief Executive Officer | Current |
| Lymphosign Inc | Chairman | Current |
| Novation Pharmaceuticals Inc | Chairman | Current |
| Rimonyx Pharmaceuticals Ltd. | Chairman of Scientific Advisory Board | Current |
| Cytochroma | Chairman | Current |
| Biotica Technology Limited | Board of Directors | Current |
| Discovery Partners International, Inc. | Director | Current |
| Quorex Pharmaceuticals, Inc. | Director | Current |
| BioMarin Pharmaceutical Inc. | Director | Current |
| Signal Pharmaceuticals, LLC | Chief Executive Officer | Former |
| Signal Pharmaceuticals, LLC | President | Former |
| Inflammation Research Association | President | Former |
| Celgene Corporation | President | Former |
| Wyeth-Ayerst | Vice President of Research | Former |
| Yale University | Research Associate | Former |
| BioMarin Pharmaceutical Inc. | Chairman | Former |
| Signal Pharmaceuticals, LLC | Director | Former |
| University of Wales | Ph.D. | Former |
| Southampton University | B.Sc. In Physiology and Biochemistry | Former |
Array
| Organization | Position | Status |
|---|---|---|
| Sequenom, Inc. | Chairman of the Board of Directors | Current |
| San Diego Opera | Member of the Board | Current |
| Discovery Partners International, Inc. | Board of Directors | Current |
| Signal Pharmaceuticals, LLC | Director | Current |
| Arena Pharmaceuticals, Inc. | Director | Current |
| Infinity Pharmaceuticals, Inc | Director | Current |
| Arena Pharmaceuticals, Inc. | Member | Current |
| Braincells, Inc. | Chief Executive Officer | Former |
| Amgen Inc. | President and Chief Operating Officer and Member | Former |
| Braincells, Inc. | Co-Founder | Former |
| Abbott Laboratories | Former | |
| Discovery Partners International, Inc. | Chairman | Former |
| Sequenom, Inc. | Board of Directors | Current |
| University of Chicago | M.B.A. | Former |
| Purdue University | B.S. In Chemical Engineering | Former |
| Amgen Inc. | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Gen-Probe Inc. | Senior Vice President, Finance and Chief Financial Officer | Current |
| ARYx Therapeutics Inc | Board of Directors | Current |
| Discovery Partners International, Inc. | Board of Directors | Current |
| Infinity Pharmaceuticals, Inc | Board of Directors | Current |
| Radnet Management Inc. | Chief Executive Officer | Former |
| Radnet Management Inc. | President | Former |
| PricewaterhouseCoopers | partner | Former |
| Cooper's Inc. | Partner | Former |
| Wharton Graduate School of the University of Pennsylvania | M.B.A. In Finance | Former |
| Wharton Graduate School of the University of Pennsylvania | B.B.A. In Finance | Former |
| Pace University | B.B.A. In Finance | Former |
| Organization | Position | Status |
|---|---|---|
| Evotech, Inc. | Chairman and Chief Executive Officer of Novacea | Current |
| Renovis, Inc. | Executive Chairman, Principal Executive Officer and Director | Former |
| Ipierian | CEO | Current |
| Bayhill Therapeutics | CEO | Current |
| MDS Capital | Investment Advisor | Current |
| Kai Pharmaceuticals, Inc | Chairman, Private Investor | Current |
| Bayhill Therapeutics | Chairman | Current |
| TRANSCEPT PHARMACEUTICALS, INC. | Director | Current |
| Geron Corporation | Board of Directors | Current |
| Saegis Pharmaceuticals, Inc | Board of Directors | Current |
| Evotech, Inc. | Board of Directors | Current |
| Discovery Partners International, Inc. | Board of Directors | Current |
| Arris | Chairman and Chief Executive Officer | Former |
| TRANSCEPT PHARMACEUTICALS, INC. | CEO | Former |
| Renovis, Inc. | Principal Executive Officer | Current |
| Centaur Pharmaceuticals | Interim Chief Executive Officer | Former |
| Morgan Stanley Venture Partners | Venture Partner | Former |
| Centaur Pharmaceuticals | Independent Consultant | Former |
| Bayhill Therapeutics | Investment Advisor | Former |
| Guava Technologies, Inc. | Investment Advisor | Former |
| Geron Corporation | Chairman | Former |
| American Hospital Supply Corporation | Former | |
| Signal Pharmaceuticals, LLC | Chairman | Former |
| Centaur Pharmaceuticals | Chairman | Former |
| Axys Pharmaceuticals | Chairman | Former |
| Microcide , Inc | Chairman | Former |
| TRANSCEPT PHARMACEUTICALS, INC. | Chairman | Former |
| Ceregene, Inc. | Professional Board Director | Former |
| Axys Pharmaceuticals | Director | Former |
| Renovis, Inc. | Director | Former |
| Guava Technologies, Inc. | Board of Directors | Former |
| Northwestern University | B.A. | Former |
| State University of New York at Buffalo | B.A. | Former |
| Discovery Partners International, Inc. | member | Former |
Array
| Organization | Position | Status |
|---|---|---|
| University of California | Adjunct Prof of Chemistry | Current |
| Global Health Limited | Executive Scientific Advisor | Current |
| University of California, San Francisco | Adjunct Professor of Chemistry | Current |
| Infinity Pharmaceuticals, Inc | Chair of Infinity's Research and Development Committee | Current |
| Innovative Salon Solutions | Board of Directors | Current |
| Discovery Partners International, Inc. | Board of Directors | Current |
| Infinity Pharmaceuticals, Inc | Acting Chief Executive Officer | Former |
| Discovery Partners International, Inc. | Chief Executive Officer | Former |
| Infinity Pharmaceuticals, Inc | Chief Scientific Officer | Former |
| Axys Pharmaceuticals | Chief Technical Officer | Former |
| Axys Pharmaceuticals | Senior Vice President, Research and Preclinical Development | Former |
| Axys Pharmaceuticals | General Manager | Former |
| Infinity Pharmaceuticals, Inc | Board of Directors | Current |
| Dartmouth College | A.B. | Former |
Executive News
-
The Fresh Market and Juvenile Diabetes Research Foundation Team Up to Find a Cure for Type 1...
-
The Fresh Market and Juvenile Diabetes Research Foundation Team Up to Find a Cure...
-
IPierian Inc. hires first CFO
-
Advance Auto Parts Launches 2009 National "Sneaker" Sales Campaign to Support Juvenile Diabetes Research Foundation (JD
-
Advance Auto Parts Launches 2009 National Sneaker Sales
-
Advance Auto Parts Launches 2009 National Sneaker Sales Campaign to Support Juvenile Diabetes Research Foundation (JDRF)
Industry Transcripts by Seeking Alpha
-
51jobs Q3 2009 Earnings Call Transcript
on Nov 23, 2009about JOBS
-
NetEase Q3 2009 Earnings Call Transcript
on Nov 18, 2009about NTES
-
Franklin Covey Co. F4Q09 (Qtr End 08/31/09) Earnings Call Transcript
on Nov 16, 2009about FC
-
Cellcom Israel Ltd. Q3 2009 Earnings Call Transcript
on Nov 16, 2009about CEL
-
URS Corporation Q3 2009 Earnings Call Transcript
on Nov 13, 2009about URS


